2008
DOI: 10.1080/00498250801927427
|View full text |Cite
|
Sign up to set email alerts
|

Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
163
0
4

Year Published

2012
2012
2022
2022

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 184 publications
(169 citation statements)
references
References 133 publications
2
163
0
4
Order By: Relevance
“…These include an interaction of nucleotides with one or more P2X (ion channel; [15]) and P2Y (G-protein-coupled; [16]) receptors and the enzymatic hydrolysis of ATP (e.g., via the sequential actions of NTPDases and CD73/ecto-5′-nucleotidase; [17]) to generate adenosine. Extracellular adenosine, in turn, can interact with one or more G-protein-coupled P1 receptors [18] or can be taken back up into cells via ENT (equilibrative nucleoside transporter [19]) to undergo metabolic fates that include the synthesis of ATP. One consequence of the activation of P1 (and certain P2Y) receptors is a change in cellular levels of cAMP, which can exit cells by certain multidrug resistant proteins (MRPs 4 and 5; [20]).…”
Section: Introductionmentioning
confidence: 99%
“…These include an interaction of nucleotides with one or more P2X (ion channel; [15]) and P2Y (G-protein-coupled; [16]) receptors and the enzymatic hydrolysis of ATP (e.g., via the sequential actions of NTPDases and CD73/ecto-5′-nucleotidase; [17]) to generate adenosine. Extracellular adenosine, in turn, can interact with one or more G-protein-coupled P1 receptors [18] or can be taken back up into cells via ENT (equilibrative nucleoside transporter [19]) to undergo metabolic fates that include the synthesis of ATP. One consequence of the activation of P1 (and certain P2Y) receptors is a change in cellular levels of cAMP, which can exit cells by certain multidrug resistant proteins (MRPs 4 and 5; [20]).…”
Section: Introductionmentioning
confidence: 99%
“…Clinically, nucleoside and nucleobase analogs are also widely used in anticancer, antiviral, and anti-protozoal therapies (1,2). Because physiological nucleosides and the majority of their synthetic analogs are hydrophilic molecules, specialized nucleoside transporter proteins are required to facilitate their movement across biological membranes.…”
mentioning
confidence: 99%
“…Because physiological nucleosides and the majority of their synthetic analogs are hydrophilic molecules, specialized nucleoside transporter proteins are required to facilitate their movement across biological membranes. Thus, nucleoside transporters play key roles in nucleoside physiology, pathophysiology, and in the therapeutic actions of many nucleoside drugs (1)(2)(3)(4)(5).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…There are four known nucleoside transport proteins in human cells (hENT1-4) that facilitate cellular uptake of nucleosides from the surroundings [36]. In both humans and mice, equilibrative nucleoside transporter 1 (ENT1) is widely expressed and responsible for the majority of adenosine transport across the plasma membrane [36]. Knockout mice lacking ENT1 display reduced adenosine uptake and increased circulating levels of adenosine in the plasma [37,38].…”
Section: Adenosine Signalingmentioning
confidence: 99%